0001493152-22-022804.txt : 20220815
0001493152-22-022804.hdr.sgml : 20220815
20220815150353
ACCESSION NUMBER: 0001493152-22-022804
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220727
FILED AS OF DATE: 20220815
DATE AS OF CHANGE: 20220815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: 10X Fund, L.P.
CENTRAL INDEX KEY: 0001453356
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 221165080
BUSINESS ADDRESS:
STREET 1: 1099 FOREST LAKE TERRACE
CITY: NICEVILLE
STATE: FL
ZIP: 32578
BUSINESS PHONE: 208-263-6695
MAIL ADDRESS:
STREET 1: 1099 FOREST LAKE TERRACE
CITY: NICEVILLE
STATE: FL
ZIP: 32578
FORMER NAME:
FORMER CONFORMED NAME: 10X FUND LP
DATE OF NAME CHANGE: 20090107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4/A
1
ownership.xml
X0306
4/A
2022-07-27
2022-08-09
0
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001453356
10X Fund, L.P.
545 DUTCH VALLEY ROAD, N.E., SUITE A
ATLANTA,
GA
30324
0
0
1
0
Common Stock
2022-07-27
4
S
0
10000
2.087
D
6168940
D
Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan.
10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
2022-08-12
/s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC
2022-08-12
/s/ James C. Czirr, Individually
2022-08-12